Cellectar Biosciences, Inc. (CLRB) stock
CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.92−0.09 (-8.88%)
Close on Nov 17, 2026Market cap $8.70MP/E –Yield –
Cellectar Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cellectar Biosciences's price to book ratio was 0.3× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.3× to 13.9×, with a median of 1.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.3× | −0.8 |
| 2025 | Dec 31, 2025 | 1.2× | +0.4 |
| 2024 | Dec 31, 2024 | 0.8× | −13.1 |
| 2023 | Jul 31, 2023 | 13.9× | +12.9 |
| 2022 | Dec 30, 2022 | 1.0× | −0.1 |
| 2021 | Dec 31, 2021 | 1.1× | −2.4 |
| 2020 | Dec 31, 2020 | 3.4× | +1.7 |
| 2019 | Dec 31, 2019 | 1.7× | +1.3 |
| 2018 | Dec 31, 2018 | 0.4× | −2.0 |
| 2017 | Dec 29, 2017 | 2.4× | +1.6 |
| 2016 | Dec 30, 2016 | 0.8× | −7.4 |
| 2015 | Dec 31, 2015 | 8.2× | +5.9 |
| 2014 | Dec 31, 2014 | 2.4× | −2.4 |
| 2013 | Dec 31, 2013 | 4.8× | +1.8 |
| 2012 | Dec 31, 2012 | 3.0× | +1.0 |
| 2011 | Dec 30, 2011 | 2.0× | – |
See a number that looks wrong?